0 Commenti
0 Condivisioni
2K Visualizzazioni
0 Recensioni
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....0 Commenti 0 Condivisioni 1K Visualizzazioni 0 Recensioni
-
Small Molecule Innovator API CDMO Market Sees Rising Adoption in Clinical-Stage Drug Development, Commercial API Manufacturing, and Lifecycle ManagementMarket Overview The Small Molecule Innovator API CDMO Market is gaining importance as pharmaceutical companies increasingly outsource active pharmaceutical ingredient development and manufacturing to specialized contract development and manufacturing organizations. Innovator drug developers often require advanced capabilities for complex molecules, stringent quality control,...0 Commenti 0 Condivisioni 225 Visualizzazioni 0 Recensioni
-
Pharmaceutical CRO Market Competitive Analysis and Key PlayersThe global Pharmaceutical CRO Market size was valued at USD 45.3 billion in 2025 and is projected to grow from USD 48.5 billion in 2026 to USD 83.3 billion by 2033, expanding at a CAGR of 8.0% from 2026 to 2033. Asia Pacific accounted for the largest market share of 26.4% in 2025, driven by increasing clinical research activities, expanding pharmaceutical outsourcing, lower...0 Commenti 0 Condivisioni 1K Visualizzazioni 0 Recensioni
-
Small Molecule Innovator API CDMO Market Trends in Process Development and Scale-UpThe global Small Molecule Innovator API CDMO market was valued at USD 26.7 billion in 2025 and is projected to grow from USD 28.1 billion in 2026 to USD 43.7 billion by 2033, registering a CAGR of 6.6% from 2026 to 2033. Asia Pacific accounted for the largest 41.9% revenue share in 2025, supported by expanding pharmaceutical manufacturing capabilities, cost-efficient production...0 Commenti 0 Condivisioni 1K Visualizzazioni 0 Recensioni
-
AI Clinical Trial Market Growing at 15% CAGR Through 2034According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...0 Commenti 0 Condivisioni 2K Visualizzazioni 0 Recensioni